Latest News & Features
Americas
Eli Lilly has sued Par Pharmaceutical for patent infringement over the drug Axiron (testosterone), used to treat men with low or no testosterone. 24 April 2017
article
Medical technology company Becton Dickinson will acquire C R Bard, a business in the same industry, for $24 billion. 24 April 2017
Americas
Japan-based Sawai Pharmaceutical has agreed to buy the generic drugs business of Upsher-Smith Laboratories for nearly $1.1 billion. 21 April 2017
Americas
Harvard Stem Cells Institute, a network of stem cell scientists, has entered into a collaboration agreement with stem cells manufacturer Cellular Dynamics International. 20 April 2017
Americas
Genetic sequencing company Illumina and Cornell University have together sought to dismiss a patent dispute over eight genetic testing patents belonging to Cornell. 20 April 2017
Americas
US-based law firm Honigman Miller Schwartz and Cohn has hired Simeon Papacostas as a partner in the firm’s IP department. 20 April 2017
Americas
Medical technology company NeuroGrafix and Toshiba Medical have entered into a settlement agreement following a patent dispute over MRI imaging technology. 19 April 2017
Americas
Shire Viropharma has filed a complaint against CSL Behring, a developer of rare disease therapies, for patent infringement. 19 April 2017
Americas
The University of California, Berkeley and the University of Vienna have appealed against the Patent Trial and Appeal Board's decision in the dispute over CRISPR technology. 18 April 2017
Asia
Takeda will sell a number of its off-patent drugs, used for treatment of diabetes, hypertension and peptic ulcers, to Teva Takeda Yakuhin for ¥28.5 billion. 17 April 2017